Atherosclerosis Drugs Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Atherosclerosis Drugs Market is expected to grow with a CAGR of 2% over the forecast period 2022-2028. 

Atherosclerosis is one of the leading causes of cardiovascular disease and some causative comorbidities associated with obesity, diabetes, overweight, an unhealthy diet, high blood pressure and elevated cholesterol levels. Various drugs, such as statins, are the first-line treatment for atherosclerosis. In addition to these, fibrates, calcium channel blockers, beta blockers, angiotensin converting enzyme inhibitors, and diuretics are used to treat atherosclerosis. PCSK 9 is also a novel treatment for coronary atherosclerotic plaque formation. Atherosclerosis is also associated with vascular disease.

Market Segments

By Drug Class

• Anti-platelet Medications
• Cholesterol Lowering Medications
• Fibric Acid and Omega-3 Fatty Acid Derivatives
• Beta Blockers
• Angiotensin-converting Enzyme (ACE) Inhibitors
• Calcium Channel Blockers
• Diuretics

Key Players

• GlaxoSmithKline Plc
• Sanofi, F. Hoffmann-La Roche Ltd
• Bayer AG
• Novartis AG
• Merck & Co., Inc. (Merck Sharp & Dohme Corp)
• Janssen Pharmaceuticals, Inc. (Johnson & Johnson)
• Mylan N.V., Amgen Inc.
• Pfizer, Inc.

Scope of the Report

The research study analyzes the global Atherosclerosis Drugs industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Atherosclerosis Drugs Market Report

1. What was the Atherosclerosis Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Atherosclerosis Drugs Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Atherosclerosis Drugs Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.